Vantage Investment Advisors’s Medtronic MDT Stock Holding History

Vantage Investment Advisors’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$7.75M	Buy	78,816 +2,206	+3%	+$204K	1.63%	21
2018 Q2	$6.56M	Buy	76,610 +75,511	+6,871%	+$6.31M	1.59%	21
2018 Q1	$88K	Sell	1,099 -120	-10%	-$9.9K	0.02%	213
2017 Q4	$98K	Sell	1,219 -615	-34%	-$49.3K	0.02%	207
2017 Q3	$143K	Hold	1,834	–	–	0.04%	161
2017 Q2	$163K	Sell	1,834 -10	-0.5%	-$843	0.05%	144
2017 Q1	$149K	Buy	1,844 +348	+23%	+$27.2K	0.05%	142
2016 Q4	$107K	Buy	1,496 +25	+2%	+$1.96K	0.04%	163
2016 Q3	$127K	Buy	1,471 +993	+208%	+$86.5K	0.06%	140
2016 Q2	$39K	Buy	478 +81	+20%	+$6.55K	0.02%	296
2016 Q1	$30K	Hold	397	–	–	0.01%	328
2015 Q4	$31K	Hold	397	–	–	0.02%	307
2015 Q3	$27K	Hold	397	–	–	0.02%	317
2015 Q2	$29K	Sell	397 -298	-43%	-$22.8K	0.02%	317
2015 Q1	$54K	Buy	695 +467	+205%	+$35.4K	0.02%	323
2014 Q4	$16K	Hold	228	–	–	0.01%	428
2014 Q3	$14K	Hold	228	–	–	0.01%	430
2014 Q2	$15K	Hold	228	–	–	0.01%	425
2014 Q1	$14K	Hold	228	–	–	0.01%	393
2013 Q4	$13K	Buy	+228	New	+$12.9K	0.01%	374

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vantage Investment Advisors's MDT Position: Q3 2018 in Review

Vantage Investment Advisors increased its Medtronic (MDT) stake by 2.9% in Q3 2018, buying an estimated $204K and bringing the position to 78,816 shares worth $7.75M. The position accounts for 1.63% of the portfolio, ranked #21.

Vantage Investment Advisors first reported a position in MDT in Q4 2013 and has held it in 20 quarters since. 1,484 funds tracked by Wall St. Rank hold MDT as of Q3 2018.

Vantage Investment Advisors held 78,816 shares of Medtronic worth $7.75M as of Q3 2018.
Vantage Investment Advisors bought 2,206 Medtronic shares in Q3 2018, an estimated $204K.
Medtronic made up 1.63% of Vantage Investment Advisors's portfolio in Q3 2018, its #21 holding.
Vantage Investment Advisors first reported a position in Medtronic in Q4 2013 and has held it in 20 quarters since.
1,484 funds tracked by Wall St. Rank held Medtronic as of Q3 2018.

Based on Vantage Investment Advisors's 13F filing for Q3 2018, filed 9 Nov 2018.